155 related articles for article (PubMed ID: 16230209)
1. Emergence of Candida albicans fungemia during voriconazole therapy.
Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D
J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
[No Abstract] [Full Text] [Related]
2. Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
Infection; 2004 Jun; 32(3):8. PubMed ID: 15230277
[No Abstract] [Full Text] [Related]
3. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Weig M; Müller FM
Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
[No Abstract] [Full Text] [Related]
5. Use of voriconazole in candida retinitis.
Varma D; Thaker HR; Moss PJ; Wedgwood K; Innes JR
Eye (Lond); 2005 Apr; 19(4):485-7. PubMed ID: 15105823
[No Abstract] [Full Text] [Related]
6. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Imhof A; Balajee SA; Fredricks DN; Englund JA; Marr KA
Clin Infect Dis; 2004 Sep; 39(5):743-6. PubMed ID: 15356792
[TBL] [Abstract][Full Text] [Related]
7. Treatment of candida chorioretinitis with voriconazole.
Jang GJ; Kim KS; Shin WS; Lee WK
Korean J Ophthalmol; 2005 Mar; 19(1):73-6. PubMed ID: 15929491
[TBL] [Abstract][Full Text] [Related]
8. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
9. Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Spellberg B; Rieg G; Bayer A; Edwards JE
Clin Infect Dis; 2003 Apr; 36(8):1091-3. PubMed ID: 12684933
[No Abstract] [Full Text] [Related]
10. Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
Bernhardt J; Bernhardt H; Knoke M; Ludwig K
Mycoses; 2004 Aug; 47(7):330-7. PubMed ID: 15310340
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
Martínez-Suárez JV; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
[No Abstract] [Full Text] [Related]
12. Successful treatment of Acremonium fungemia with voriconazole.
Mattei D; Mordini N; Lo Nigro C; Gallamini A; Osenda M; Pugno F; Viscoli C
Mycoses; 2003 Dec; 46(11-12):511-4. PubMed ID: 14641626
[TBL] [Abstract][Full Text] [Related]
13. When candida turns deadly.
Randolph S
RN; 2002 Mar; 65(3):41-4; quiz 45. PubMed ID: 11961868
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Candida dubliniensis fungemia at a large teaching hospital.
Jabra-Rizk MA; Johnson JK; Forrest G; Mankes K; Meiller TF; Venezia RA
Clin Infect Dis; 2005 Oct; 41(7):1064-7. PubMed ID: 16142677
[TBL] [Abstract][Full Text] [Related]
15. Zygomycete infection following voriconazole prophylaxis.
van Well GT; van Groeningen I; Debets-Ossenkopp YJ; van Furth AM; Zwaan CM
Lancet Infect Dis; 2005 Sep; 5(9):594. PubMed ID: 16122683
[No Abstract] [Full Text] [Related]
16. [Voriconazole - applications and perspectives].
Ruhnke M
Mycoses; 2002; 45 Suppl 3():42-7. PubMed ID: 12690971
[TBL] [Abstract][Full Text] [Related]
17. Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
van Hal SJ; Clezy K
HIV Med; 2005 Jan; 6(1):45-6. PubMed ID: 15670252
[No Abstract] [Full Text] [Related]
18. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
Sanglard D; Odds FC
Lancet Infect Dis; 2002 Feb; 2(2):73-85. PubMed ID: 11901654
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough Candida infections in patients receiving voriconazole.
Gerzenshtein L; Patel SM; Scarsi KK; Postelnick MJ; Flaherty JP
Ann Pharmacother; 2005; 39(7-8):1342-5. PubMed ID: 15914520
[TBL] [Abstract][Full Text] [Related]
20. Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Hegener P; Troke PF; Fätkenheuer G; Diehl V; Ruhnke M
AIDS; 1998 Nov; 12(16):2227-8. PubMed ID: 9833866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
